Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Christopher Sorli"'
Autor:
Julie Derving Karsbøl, Shin-ichi Harashima, Stephen C. Bain, Thomas Kruse Hansen, George Tsoukas, Jeffrey Unger, Christopher Sorli
Publikováno v:
The Lancet Diabetes & Endocrinology. 5:251-260
Summary Background Despite a broad range of pharmacological options for the treatment of type 2 diabetes, optimum glycaemic control remains challenging for many patients and new therapies are necessary. Semaglutide is a glucagon-like peptide-1 (GLP-1
Publikováno v:
Current Medical Research and Opinion. 31:1809-1815
Past studies have found episodes of severe hypoglycemia (SH) to be serially dependent. Those studies, however, only considered the impact of a single (index) event on future risk; few have analyzed SH risk as it evolves over time in the presence (or
Autor:
Christopher Sorli
Publikováno v:
The American Journal of Medicine. 127:S39-S48
Insulin has classically been considered a treatment of last resort for individuals with type 2 diabetes, delayed until all other efforts by the patient and healthcare provider have failed. Recent treatment guidelines recommend the use of insulin, in
Autor:
C. W. le Roux, Dimitrios J. Pournaras, Jakeline Luiz Corrêa, Paulo Sakai, Christopher Sorli, Bruno da Costa Martins, Carlos A. Schiavon, Tarissa Petry, M. Galvao Neto, Ricardo Cohen, Dimitris Papamargaritis, João E. Salles
Publikováno v:
Diabetic Medicine. 30:1482-1486
To report Type 2 diabetes-related outcomes after the implantation of a duodenal-jejunal bypass liner device and to investigate the role of proximal gut exclusion from food in glucose homeostasis using the model of this device.Sixteen patients with Ty
Autor:
Jelena Vukmirica, Esteban Jódar, Christopher Sorli, Keval Chandarana, Ildiko Lingvay, Jakob Langer, Stewart B. Harris, Elmar Jaeckel
Publikováno v:
Canadian Journal of Diabetes. 41:S58
Autor:
Stewart B. Harris, Trine Julie Abrahamsen, Christopher Sorli, Jelena Vukmirica, Keval Chandarana, Esteban Jódar, Elmar Jaeckel, Ildiko Lingvay
Publikováno v:
Canadian Journal of Diabetes. 41:S58
Autor:
Stewart B. Harris, keval Chandrana, Narimène Belhatem, Bertrand Cariou, Ildiko Lingvay, Elmar Jaeckel, Christopher Sorli, Esteban Jódar, Trine Julie Abrahamsen
Publikováno v:
Diabetes & Metabolism. 43:A114
Autor:
Bruce A. Woda, Nancy E. Phillips, Thomas G. Markees, Christopher Sorli, David V. Serreze, Dale L. Greiner, Ethel J. Gordon, Aldo A. Rossini, Randolph J. Noelle, Leonard D. Shultz, John P. Mordes
Publikováno v:
Diabetes. 48:967-974
A protocol consisting of a single donor-specific transfusion (DST) plus a brief course of anti-CD154 monoclonal antibody (anti-CD40 ligand mAb) induces permanent islet allograft survival in chemically diabetic mice, but its efficacy in mice with auto
Autor:
Hui-Jian Zhang, Christopher Sorli, R. Paul Robertson, Michael B. Armstrong, Jacques Maclouf, Ray V. Rajotte
Publikováno v:
Proceedings of the National Academy of Sciences. 95:1788-1793
The enzyme cyclooxygenase (COX)-1 is constitutive whereas COX-2 is regulated in virtually all tissues. To assess whether this dogma holds true in the pancreatic islet, we examined basal and interleukin (IL)-1-regulated expression of COX-2 in HIT-T15
Autor:
Manoel Galvao Neto, Tarissa Petry, Bruno da Costa Martins, Paulo Sakai, Carlos A. Schiavon, José Luis Lopes Correa, Cristina Mamedio, João E. Salles, Ricardo Cohen, Christopher Sorli
Publikováno v:
The Journal of clinical endocrinology and metabolism. 98(2)
The duodenal-jejunal bypass liner (DJBL) is a device that mimics the intestinal portion of gastric bypass surgery and has been shown to improve glucose metabolism rapidly in obese subjects with type 2 diabetes (T2DM).To assess the safety of the DJBL